Rutgers Clinical Research Organization connects industry, patients, and academic collaborators with the university's academic resources. Annually, Rutgers supports approximately 350 clinical trials, including industry-sponsored and our own investigator-initiated studies. In total, more than 200 principal investigators are currently conducting clinical trials in more than 50 therapeutic areas dedicated to moving forward discovery in drugs, biologics, devices, preventive and therapeutic strategies, behavioral research, and other interventions to improve human life.
The Rutgers Biomedical and Health Sciences (RBHS) Clinical Research Organization offers key advantages:
Companies wishing to conduct a clinical trial with an experienced investigator or to gain access to resources to support analysis or help initiating a project can contact the Clinical Research Organization. We will match you with an investigator or the appropriate individuals.